Stone Summit Wealth’s Teva Pharmaceuticals TEVA Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $185K | Sell |
11,020
-2,000
| -15% | -$33.5K | 0.06% | 142 |
|
|
2025
Q1 | $200K | Hold |
13,020
| – | – | 0.07% | 140 |
|
|
2024
Q4 | $287K | Hold |
13,020
| – | – | 0.1% | 123 |
|
|
2024
Q3 | $235K | Hold |
13,020
| – | – | 0.08% | 137 |
|
|
2024
Q2 | $212K | Hold |
13,020
| – | – | 0.08% | 134 |
|
|
2024
Q1 | $184K | Hold |
13,020
| – | – | 0.06% | 140 |
|
|
2023
Q4 | $136K | Hold |
13,020
| – | – | 0.05% | 139 |
|
|
2023
Q3 | $133K | Hold |
13,020
| – | – | 0.06% | 138 |
|
|
2023
Q2 | $98K | Hold |
13,020
| – | – | 0.04% | 137 |
|
|
2023
Q1 | $115K | Hold |
13,020
| – | – | 0.05% | 133 |
|
|
2022
Q4 | $119K | Hold |
13,020
| – | – | 0.06% | 130 |
|
|
2022
Q3 | $105K | Hold |
13,020
| – | – | 0.06% | 123 |
|
|
2022
Q2 | $98K | Buy |
13,020
+20
| +0.2% | +$151 | 0.06% | 129 |
|
|
2022
Q1 | $122K | Buy |
13,000
+2,000
| +18% | +$18.8K | 0.07% | 129 |
|
|
2021
Q4 | $88K | Buy |
+11,000
| New | +$88K | 0.07% | 103 |
|